As fertility care in India undergoes a significant transformation, advancements in assisted reproductive technologies are reshaping how IVF laboratories operate and deliver outcomes. With increasing demand for accessible, data-driven, and patient-centric fertility solutions, conversations around innovation, standardisation, and technology adoption have become more important than ever.

In an exclusive conversation with Dr. Asawari Savant, Elets News Network (ENN), A.R. Ghatak, Senior Vice President at Hana Health (by DSS Imagetech), shares insights on the evolving IVF landscape, the role of AI and automation in embryology, and the innovations poised to define the future of reproductive medicine in India.

India’s fertility and assisted reproductive technology (ART) ecosystem is witnessing rapid growth, driven by rising awareness, delayed parenthood, and technological advancements. From Hana Health’s perspective, what are the key shifts shaping the IVF market today, and how do you see the sector evolving over the next few years?

India’s fertility and Assisted Reproductive Technology (ART) ecosystem is evolving rapidly, driven by rising awareness, delayed parenthood, changing lifestyles, and technological advancements. Fertility conversations are becoming more mainstream, encouraging more couples to proactively explore treatment options.

A key shift shaping the IVF market today is the integration of technology across fertility care. 

New technologies like AI-assisted embryo assessment, time-lapse incubators and automated vitrification are making IVF treatments more accurate and effective. AI  is not just helping with embryo selection but with the whole process the time-lapse incubators track embryo development molecular diagnostics which helps in improving precision, consistency and treatment outcomes. IVF centers are also improving their laboratories with better workflows and evidence-based treatment methods to achieve better results. The demand for IVF is also increasing in Tier II and Tier III cities because awareness is growing and treatments are becoming much more affordable and accessible. 

Hana Health is positioning itself at the intersection of IVF, embryology, and advanced reproductive technologies. How are innovations such as AI-assisted embryo assessment, time-lapse imaging, and automated vitrification transforming IVF laboratories and clinical outcomes?

These technologies are making IVF labs more precise, consistent, and data driven. Traditionally, embryo grading relied heavily on visual assessment and the expertise of embryologists, which could sometimes vary across clinics. AI-assisted embryo assessment brings greater objectivity by analysing thousands of embryo images and identifying subtle patterns that may not be visible to the human eye, helping clinicians select embryos with higher implantation potential. 

At Hana Health, we use AI to analyze embryo images and clinical data and provide a score that predicts the chances of pregnancy which helps doctors make more informed and accurate decisions. AI is not replacing embryologists but helping them in their work and being more accurate. Time-lapse imaging allows embryos to be monitored continuously without causing any disturbance to them, as automated vitrification makes embryo freezing more consistent and reliable. These technologies are improving lab efficiency, standardization and overall IVF success rates.

Unlike equipment suppliers, Hana Health provides a wider ecosystem of IVF technologies, consumables, and laboratory support. What motivated this integrated business approach, and how does it create value for fertility centers and embryologists? 

We recognized early on that IVF labs need more than just equipment. Even the best technology can’t deliver results unless the entire lab ecosystem works well together. The primary focus is on fertility centers and IVF labs. That’s why we developed an integrated approach, allowing clinics to access technologies, consumables, workflow support, and technical guidance within one ecosystem. The aim is to enhance fertility centers and IVF labs. For fertility centers, this approach improves coordination and simplifies daily operations. 

For embryologists, it creates a reliable and standardized lab environment, allowing them to concentrate on outcomes rather than operational challenges. The goal is to enhance fertility centers and IVF labs. We see ourselves as long-term partners to fertility clinics rather than just suppliers. Our mission is to help clinics build future-ready IVF laboratories. The focus is on improving fertility centers and IVF labs. 

While fertility treatments are becoming more advanced, access and affordability remain major challenges across many parts of India. In your view, how can technology and standardized lab workflows help bridge these gaps and make quality fertility care more widely available?

Access to quality fertility care remains a challenge in India, particularly outside major cities. One advantage of technology and standardized workflows is that they help clinics operate more efficiently and consistently. The focus is on improving access to fertility care. When IVF labs adopt standardized processes and automation where needed, it reduces variability and enhances overall workflow management. Over time, this can enable clinics to scale effectively while maintaining quality standards. The aim is to improve access to fertility care. Technology is also aiding new fertility centers in setting up labs without requiring highly complex infrastructure from the beginning. This is especially crucial for Tier 2 and Tier 3 markets, where demand for fertility care is steadily increasing. The focus is on improving access to fertility care. 

Hana Health has been introducing globally advanced IVF technologies to the Indian market. What factors do you consider while selecting international technology partners, and how do you ensure these innovations are adapted effectively for Indian fertility clinics?

When choosing technology partners, first and foremost we look at whether the technology can genuinely improve lab performance and produce better patient outcomes. We focus more on the innovation, their scientific credibility, its reliability and how practical it is for IVF labs in India. Since each clinic operates differently, technologies must integrate seamlessly into existing workflows and are scalable for various types of fertility centers. The goal is to improve IVF labs and embryologists. 

Successful adoption relies heavily on training and implementation. That’s why we work closely with clinics and embryologists to offer guidance, workflow support, and hands-on training as needed. The focus is on improving IVF labs and embryologists. Our aim is not just to bring global technologies to India but to ensure they are adapted appropriately for real lab settings here. The goal is to improve IVF labs and embryologists.

Also read: From Diagnosis to Outcomes: Why Follow-Through Is Healthcare’s Next Priority

As fertility care becomes increasingly technology-driven, what are Hana Health’s strategic priorities for the coming years, and which emerging innovations do you believe will have the most significant impact on the future of reproductive medicine in India?

At Hana Health, our focus will be to continue improving the IVF laboratories in India through technology, better workflows and increased standardization. One of our key priorities will be to make advanced embryology and IVF technologies more accessible while also supporting clinics with training and lab optimization.

We are also aiming to collaborate with technology innovators so that Indian fertility centers are at benefit from the latest developments in reproductive medicine.

In the coming years, technologies like AI-assisted embryo assessment, automation in IVF labs, non-invasive embryo evaluation and advanced cryopreservation methods are expected to play a major role in shaping the future of reproductive medicine in India. Our next step is to bring technology that combines advanced optical module to analyze and AI tools to classify embryos based on their metabolic profiles. This will be a game changer in IVF clinics in India as far as success rate is concerned.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!